Biotinylated chitosan-based SPIONs with potential in blood-contacting applications
Source abstract
Abstract
Haemocompatible biotinylated superparamagnetic nanoparticles (size range 300–700 nm) have been obtained by coating magnetite through ionic gelation with a mixture of chitosan and sodium tripolyphosphate, followed by subsequent functionalisation with biotin. The evaluations of their magnetic properties together with haemocompatibility tests have shown that these nanoparticles exhibit the prerequisite behaviour for use in magnetic field–assisted separations within biological systems.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Polymer Surface Interaction Studies · Advanced Drug Delivery Systems
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (43)
Show source-provided references
1. Ambegia E, Ansell S, Cullis P, Heyes J, Palmer L, MacLachlan I (2005) Stabilized plasmid–lipid particles containing PEG-diacylglycerols exhibit extended circulation lifetimes and tumor selective gene expression. Biochim Biophys Acta - Biomembranes 2:155–16310.1016/j.bbamem.2005.02.001 ↗
2. Arbab AS, Bashaw LA, Miller BR, Jordan EK, Lewis BK, Kalish H, Frank JA (2003) Characterization of biophysical and metabolic properties of cells labeled with superparamagnetic iron oxide nanoparticles and transfection agent for cellular MR imaging. Radiology 229:838–84610.1148/radiol.2293021215 ↗
3. Arruebo M, Fernández-Pacheco R, Ibarra MR, Santamaria J (2007) Magnetic nanoparticles for drug delivery. Nano Today 2:22–3210.1016/S1748-0132(07)70084-1 ↗
4. Bao H, Li L, Zhang H (2008) Influence of cetyltrimethylammonium bromide on physicochemical properties and microstructures of chitosan–TPP nanoparticles in aqueous solutions. J Colloid Interface Sci 328:270–27710.1016/j.jcis.2008.09.003 ↗
5. Berry CC, Wells S, Charles S, Curtis AS (2003) Dextran and albumin derivatised iron oxide nanoparticles: influence on fibroblasts in vitro. Biomaterials 24:4551–455710.1016/S0142-9612(03)00237-0 ↗
6. Berry CC, Wells S, Charles S, Aitchison G, Curtis AS (2004) Cell response to dextran-derivatised iron oxide nanoparticles post internalization. Biomaterials 25:5405–541310.1016/j.biomaterials.2003.12.046 ↗
7. Bhumkar DR, Pokharkar VB (2006) Studies on effect of pH on cross-linking of chitosan with sodium tripolyphosphate: a technical note. AAPS PharmSciTech 7:E138–E14310.1208/pt070250 ↗
8. Calvo P, Remunan-Lopez C, Vila-Jato JL, Alonso MJ (1997) Novel hydrophilic chitosan-polyethylene oxide nanoparticles as protein carriers. J Appl Polym Sci 63:125–13210.1002/(SICI)1097-4628(19970103)63:1<125::AID-APP13>3.0.CO;2-4 ↗
9. Chen H, Kaminski MD, Liu X, Mertz CJ, Xie Y, Torno MD, Rosengart AJ (2007) A novel human detoxification system based on nanoscale bioengineering and magnetic separation techniques. Med Hypotheses 68(5):1071–107910.1016/j.mehy.2005.04.047 ↗
10. Chen JP, Yang PC, Ma YH, Wu T (2011) Characterization of chitosan magnetic nanoparticles for in situ delivery of tissue plasminogen activator. Carbohydr Polym 84:364–37210.1016/j.carbpol.2010.11.052 ↗
11. Choi J, Lee J, Lee YB, Hong JH, Kim IS, Park YK, Hur NH (2006) Immobilization of biomolecules on biotinylated magnetic ferrite nanoparticles. Chem Phys Lett 428:125–12910.1016/j.cplett.2006.06.092 ↗
12. Dash M, Chiellini F, Ottenbrite RM, Chiellini E (2011) Chitosan-a versatile semi-synthetic polymer in biomedical applications. Prog Polym Sci 36:981–101410.1016/j.progpolymsci.2011.02.001 ↗
13. Furumoto K, Nagayama S, Ogawara K, Takakura Y, Hashida M, Higaki K, Kimura T (2004) Hepatic uptake of negatively charged particles in rats: possible involvement of serum proteins in recognition by scavenger receptor. J Control Release 1:133–14110.1016/j.jconrel.2004.03.004 ↗
14. Gan Q, Wang T, Cochrane C, McCarron P (2005) Modulation of surface charge, particle size and morphological properties of chitosan-TPP nanoparticles intended for gene delivery. Colloids Surf B 44:65–7310.1016/j.colsurfb.2005.06.001 ↗
15. Grenha A, Seijo B, Remunan-Lopez C (2005) Microencapsulated chitosan nanoparticles for lung protein delivery. Eur J Pharm Sci 25:427–43510.1016/j.ejps.2005.04.009 ↗
16. Gupta AK, Curtis AS (2004) Surface modified superparamagnetic nanoparticles for drug delivery: interaction studies with human fibroblasts in culture. J Mater Sci Mater Med 15:493–49610.1023/B:JMSM.0000021126.32934.20 ↗
17. Gupta AK, Gupta M (2005) Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 26:3995–402110.1016/j.biomaterials.2004.10.012 ↗
18. Hansson KM, Tosatti S, Isaksson J, Wettero J, Textor M, Lindahl TL, Tengvall P (2005) Whole blood coagulation on protein-adsortion resistant-PEG and functionalized PEG-coated titanium surfaces. Biomaterials 26(8):861–87210.1016/j.biomaterials.2004.03.036 ↗
19. He C, Hu Y, Yin L, Tang C, Yin C (2010) Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles. Biomaterials 13:3657–366610.1016/j.biomaterials.2010.01.065 ↗
20. Hedge S, Kapoor S, Mukherjee T (2006) Self-assembly of Ag nanoparticle-biotin composites into long fiberlike microstructures. J Colloid Interface Sci 297:637–64310.1016/j.jcis.2005.11.029 ↗
21. Hritcu D, Popa MI, Popa N, Badescu V, Balan V (2009) Preparation and characterization of magnetic chitosan nanospheres. Turk J Chem 33:785–796
22. Kasaai MR (2010) Determination of the degree of N-acetylation for chitin and chitosan by various NMR spectroscopy techniques: a review. Carbohydr Polym 79:801–91010.1016/j.carbpol.2009.10.051 ↗
23. Klug HP, Alexander LE (1962) X-ray diffraction procedures for polycrystalline and amorphous materials. Wiley, New York, pp 491–538
24. Kumagai M, Imai Y, Nakamura T, Yamasaki Y, Sekino M, Ueno S, Hanaoka K, Kikuchi K, Nagano T, Kaneko E, Shimokado K, Kataoka K (2007) Iron hydroxide nanoparticles coated with poly(ethylene glycol)-poly(aspartic acid) block copolymer as novel magnetic resonance contrast agents for in vivo cancer imaging. Colloid Surf Biointerf 1–2:174–18110.1016/j.colsurfb.2006.12.019 ↗
25. Laurent S, Forge D, Port M, Roch A, Robic C, Vander Elast L, Muller RN (2008) Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. Chem Rev 108:2064–207010.1021/cr068445e ↗
26. Lazhen S, Yongsheng Q, Yong G, Junru T (2010) Preparation of nanometer-sized black iron oxide pigment by recycling of blast furnace flue dust. J Hazard Mater 177:495–50010.1016/j.jhazmat.2009.12.060 ↗
27. Lee ST, Mi FL, Shen YJ, Shyu SS (2001) Equilibrium and kinetic studies of copper(II) ion uptake by chitosan-tripolyphosphate chelating resin. Polymer 42:1879–189210.1016/S0032-3861(00)00402-X ↗
28. Lopez-Leon T, Carvalho ELS, Seijo B, Ortega-Vinuesa JL, Bastos-Gonzalez DJ (2005) Physicochemical characterization of chitosan nanoparticles: electrokinetic and stability behavior. J Colloid Interface Sci 283:344–35110.1016/j.jcis.2004.08.186 ↗
29. Ma H, Qi X, Maitani Y, Nagai T (2007) Preparation and characterization of superparamagnetic iron oxide nanoparticles stabilized by alginate. Int J Pharm 333:177–18610.1016/j.ijpharm.2006.10.006 ↗
30. Mayer A, Vadon M, Rinner B, Novak A, Wintersteiger R, Eleonore Fröhlich E (2009) The role of nanoparticle size in hemocompatibility. Toxicology 2–3:139–14710.1016/j.tox.2009.01.015 ↗
31. Mikhaylova M, Kim DK, Bobrysheva N, Osmolowsky M, Semenov V, Tsakalatos T, Muhammed M (2004) Superparamagnetism of magnetite nanoparticles: dependence on surface modification. Langmuir 20:2472–247710.1021/la035648e ↗
32. Nielsen VG, Khan ES, Kirklin JK, George JF (2010) Carbon monoxide releasing molecule-2 enhances coagulation and diminishes fibrinolytic vulnerability in subjects exposed to warfarin. Thromb Res 126:68–7310.1016/j.thromres.2010.03.011 ↗
33. Pankhurst QA, Connolly J, Jones SK, Dobson J (2003) Applications of magnetic nanoparticles in biomedicine. J Phys D 36:167–18110.1088/0022-3727/36/13/201 ↗
34. Papadimitriou S, Bikiaris D, Avgoustakis K, Karavas E, Georgarakis M (2008) Chitosan nanoparticles loaded with dorzolamide and pramipexole. Carbohydr Polym 73:44–5410.1016/j.carbpol.2007.11.007 ↗
35. Singha N, Jenkinsa GJS, Asadib R, Doak SH (2010) Potential toxicity of superparamagnetic iron oxide nanoparticles (SPION). Nano Rev 1:5358. doi: 10.3402/nano.v1i0.535810.3402/nano.v1i0.5358 ↗
36. Sun C, Lee J, Zhang M (2008) Magnetic nanoparticles in MR imaging and drug delivery. Adv Drug Deliv Rev 60:1252–126510.1016/j.addr.2008.03.018 ↗
37. Sze A, Erickson D, Ren LQ, Li DQ (2003) Zeta-Potential measurement using the smoluchowski equation and the slope of the current-time relationship in electroosmotic. J Colloid Interface Sci 261:402–41010.1016/S0021-9797(03)00142-5 ↗
38. Taylor DJF, Thomas RK, Penfold J (2007) Polymer/surfactant interaction at the air/water interface. Adv Colloid Interface Sci 132:69–11010.1016/j.cis.2007.01.002 ↗
39. Tsai ML, Bai SW, Chen RH (2008) Cavitation effects versus stretch effects resulted in different size and polydispersity of ionotropic gelation chitosan-sodium tripolyphosphate nanoparticle. Carbohydr Polym 7:448–45710.1016/j.carbpol.2007.06.015 ↗
40. Wu Y, Yang W, Wang C, Hu J, Fu S (2005) Chitosan nanoparticles as a novel delivery system for ammonium glycyrrhizinate. Int J Pharm 295:235–24510.1016/j.ijpharm.2005.01.042 ↗
41. Zhang H, Oh M, Allen C, Kumacheva E (2004) Monodisperse chitosan nanoparticles for mucosal drug delivery. Biomacromolecules 5:2461–246810.1021/bm0496211 ↗
42. Zhao H, Saatchi K, Häfeli U (2009) Preparation of biodegradable magnetic microspheres with poly(lactic acid)-coated magnetite. J Magn Magn Mater 10:1356–136310.1016/j.jmmm.2009.02.038 ↗
43. Zhu S, Huang N, Xu L, Zhang Y, Liu H, Lei Y, Sun H, Yao Y (2009) Biocompatibility of Fe–O films synthesized by plasma immersion ion implantation and deposition. Surf Coat Tech 203(11):1523–152910.1016/j.surfcoat.2008.11.033 ↗